FUDANZHANGJIANG (01349) turns around, Q1-3 profit RMB38.41M X
29/10/2026 18:02
(Infocast News)      Results of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (01349) for the first three quarters ended 30 September 2026:

Net profit: RMB38.4099M (RMB15.9365M net loss for the same period last year) 
Basic EPS: RMB0.04


(WL)

(C) Copyright by Infocast Ltd. All Rights Reserved.

Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.